These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 3413127)

  • 21. A noninfectious simian/human immunodeficiency virus DNA vaccine that protects macaques against AIDS.
    Singh DK; Liu Z; Sheffer D; Mackay GA; Smith M; Dhillon S; Hegde R; Jia F; Adany I; Narayan O
    J Virol; 2005 Mar; 79(6):3419-28. PubMed ID: 15731236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys.
    Shibata R; Igarashi T; Haigwood N; Buckler-White A; Ogert R; Ross W; Willey R; Cho MW; Martin MA
    Nat Med; 1999 Feb; 5(2):204-10. PubMed ID: 9930869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of HIV-1 IIIB infection in chimpanzees by CD4 immunoadhesin.
    Ward RH; Capon DJ; Jett CM; Murthy KK; Mordenti J; Lucas C; Frie SW; Prince AM; Green JD; Eichberg JW
    Nature; 1991 Aug; 352(6334):434-6. PubMed ID: 1907354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The first successful AIDS vaccine: immunization of chimpanzees confers protection against challenge with human immunodeficiency virus.
    Moor-Jankowski J
    J Med Primatol; 1991; 20(1):47-8. PubMed ID: 2051469
    [No Abstract]   [Full Text] [Related]  

  • 25. Safety of an intravenous immunoglobulin preparation: lack of seroconversion for human immunodeficiency virus antibodies.
    Lee ML; Kingdon HS; Hooper J; Courter SG; Holst SL; Piszkiewicz D
    Clin Ther; 1987; 9(3):300-3. PubMed ID: 3111704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-GP 120 antibodies from HIV seropositive individuals mediate broadly reactive anti-HIV ADCC.
    Lyerly HK; Reed DL; Matthews TJ; Langlois AJ; Ahearne PA; Petteway SR; Weinhold KJ
    AIDS Res Hum Retroviruses; 1987; 3(4):409-22. PubMed ID: 2833917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Titration of a vaccine stock preparation of human immunodeficiency virus type 1SF2 in cultured lymphocytes and in chimpanzees.
    Murthy KK; Cobb EK; el-Amad Z; Ortega H; Hsueh FC; Satterfield W; Lee DR; Kalish ML; Haigwood NL; Kennedy RC; Steimer KS; Schultz A; Levy JA
    AIDS Res Hum Retroviruses; 1996 Sep; 12(14):1341-8. PubMed ID: 8891113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutralizing antibodies and the course of HIV-induced disease.
    Wendler I; Bienzle U; Hunsmann G
    AIDS Res Hum Retroviruses; 1987; 3(2):157-63. PubMed ID: 3650100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of transmission of human immunodeficiency virus from infected to uninfected chimpanzees.
    Fultz PN; Greene C; Switzer W; Swenson B; Anderson D; McClure HM
    J Med Primatol; 1987; 16(6):341-7. PubMed ID: 3480958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specificity of chimpanzee antibodies binding a strain-specific HIV-1 neutralization epitope of the external envelope.
    Goudsmit J; Bakker M; Smit L; Meloen RH
    J Med Primatol; 1989; 18(3-4):357-62. PubMed ID: 2474656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adenovirus vectored vaccines.
    Natuk RJ; Davis AR; Chanda PK; Lubeck MD; Chengalvala M; Murthy SC; Wade MS; Dheer SK; Bhat BM; Murthy KK
    Dev Biol Stand; 1994; 82():71-7. PubMed ID: 7958485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absence of seroconversion following treatment with hepatitis B immune globulin containing antibody to human immunodeficiency virus.
    Phillips M; Cummins LM
    Hepatology; 1988; 8(3):497-8. PubMed ID: 3371869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of human immunodeficiency virus (HIV) human hyperimmune immunoglobulin in HIV type 1-infected children (Pediatric AIDS clinical trials group protocol 273).
    Stiehm ER; Fletcher CV; Mofenson LM; Palumbo PE; Kang M; Fenton T; Sapan CV; Meyer WA; Shearer WT; Hawkins E; Fowler MG; Bouquin P; Purdue L; Sloand EM; Nemo GJ; Wara D; Bryson YJ; Starr SE; Petru A; Burchett S
    J Infect Dis; 2000 Feb; 181(2):548-54. PubMed ID: 10669338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Temporal development of cross-neutralization between HTLV-III B and HTLV-III RF in experimentally infected chimpanzees.
    Goudsmit J; Thiriart C; Smit L; Bruck C; Gibbs CJ
    Vaccine; 1988 Jun; 6(3):229-32. PubMed ID: 3166553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Active and passive immunization against HIV type 1 infection in chimpanzees.
    Murthy KK; Cobb EK; Rouse SR; McClure HM; Payne JS; Salas MT; Michalek GR
    AIDS Res Hum Retroviruses; 1998 Oct; 14 Suppl 3():S271-6. PubMed ID: 9814955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for rapid selection and deletion of HIV-1 subpopulations in vivo by V3-specific neutralizing antibody: a model of humoral-associated selection.
    Nara P; Smit L; Dunlop N; Hatch W; Merges M; Waters D; Kelliher J; Krone W; Goudsmit J
    Dev Biol Stand; 1990; 72():315-41. PubMed ID: 2282990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of hyperimmune anti-human immunodeficiency virus immunoglobulin in persons with AIDS.
    Fletcher CV; Goodroad BK; Cummins LM; Henry K; Balfour HH; Rhame FS
    Antimicrob Agents Chemother; 1997 Jul; 41(7):1571-4. PubMed ID: 9210687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immunization against the human immunodeficiency virus in Zaire].
    Zagury D; Salaün JJ; Bernard J; Dechazal L; Goussard B; Lurhuma Z
    Med Trop (Mars); 1988; 48(4):417-23. PubMed ID: 3221792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protection of rhesus monkeys against infection with minimally pathogenic simian-human immunodeficiency virus: correlations with neutralizing antibodies and cytotoxic T cells.
    Quinnan GV; Yu XF; Lewis MG; Zhang PF; Sutter G; Silvera P; Dong M; Choudhary A; Sarkis PT; Bouma P; Zhang Z; Montefiori DC; Vancott TC; Broder CC
    J Virol; 2005 Mar; 79(6):3358-69. PubMed ID: 15731230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Where are we now with vaccines against AIDS?
    Schild GC; Stott EJ
    BMJ; 1993 Apr; 306(6883):947-8. PubMed ID: 8490466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.